MedTrace Logo

Treatment Outcomes of Advanced Neoplasia in IBD

NCT05674773 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 189

Last updated 2023-01-06

No results posted yet for this study

Summary

In this study, we aimed to (1) compare cumulative incidences of synchronous and metachronous colorectal neoplasia as well as mortality following AN in CD and UC patients who underwent proctocolectomy, (sub)total colectomy, partial colectomy or endoscopic resection, and (2) to determine factors associated with AN treatment choice.

Conditions

  • Inflammatory Bowel Diseases

Interventions

PROCEDURE

Endoscopic or surgical resection

endoscopic or surgical (partial, (sub)total, proctocolectomy) resection

Sponsors & Collaborators

  • Rijnstate Hospital

    collaborator OTHER

  • Jeroen Bosch Ziekenhuis

    collaborator OTHER

  • University Medical Center Groningen

    collaborator OTHER

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • Erasmus Medical Center

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Frank Hoentjen, MD, PhD · Radboudumc and University of Alberta

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-21
Primary Completion
2022-12-31
Completion
2023-07-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05674773 on ClinicalTrials.gov